GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
1.8k
c/survodutide·posted 1 year ago by u/trialwatch_theo

[Meta] proposal — a flair for dual agonist posts

Caution Receipts ×4 Cold Box ×2

Confession thread, sort of.

I went from 12.5mg to 5mg much faster than I should have because the scale had stalled and I got impatient. The stall broke about 2 weeks later, at which point I had no way of knowing whether the dose increase did anything or whether it would have broken anyway.

So now I have reflux I did not need and a data point I cannot interpret. Two lessons in one.

Posting it in the hope that somebody at week 69 reads it before doing the same thing.

1,927 up / 169 down92% upvoted53 commentsid 1uz9k910 Sep 2024

53 comments

23 in this archive, depth 5

best — the order this archive was captured in

u/nadia_kjaer174 points·1 year ago

This is correct. Do not generalise from tirzepatide.

replysharereportpermalink
u/santiago_villalobos102 points·1 year ago
genuine question, not being difficult: how do you know
replysharereportpermalink
u/vitamin_d_void58 points·1 year ago

Crossposting this to c/bloodwork because the people who need it are not reading this community.

replysharereportpermalink
u/trialwatch_theoOPtrial nerd42 points·1 year ago

Crossposting this to c/bloodwork because the people who need it are not reading this community.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/trialwatch_theoOPtrial nerd21 points·1 year ago

the heart rate signal is real in the data

replysharereportpermalink
u/nora_oyelaran7 points·1 year ago

rodent survodutide is investigation only

replysharereportpermalink
[removed]28 points·1 year ago

[removed by moderator]

replysharereportpermalink
u/jarno_adeyemi50 points·1 year ago

hepatic fat and MASH are the story

replysharereportpermalink
u/trialwatch_theoOPtrial nerd30 points·1 year ago

The thing nobody prepared me for was the quiet. Not the appetite, the quiet. The constant negotiation in my head about food just stopped.

replysharereportpermalink
u/rafael_sjoberg42 points·1 year ago

the safety profile is not just tirzepatide amplified

replysharereportpermalink
u/injection_site_iris23 points·1 year ago

the heart rate signal is real in the data

replysharereportpermalink
u/endotoxin_elliemicro-7 points·1 year ago

glucagon co-agonism has a different safety story

replysharereportpermalink
u/refund_ledger1 point·1 year ago

Not convinced. The evidence does not support that reading.

replysharereportpermalink
u/refund_ledger26 points·1 year ago

I love that this community will spend 40 comments on a detail. That pedantry is why the numbers here matter.

replysharereportpermalink
u/yannick_petrov11 points·1 year ago

the heart rate signal is real in the data

replysharereportpermalink
u/ismael_nwosu14 points·1 year ago

the heart rate signal is real in the data

Yes, exactly this, and it is the bit that took me 75 weeks to accept.

replysharereportpermalink
u/meera_sandvik10 points·1 year ago

do not generalise from tirzepatide

replysharereportpermalink
u/rania_marchand23 points·1 year ago

This is correct. Do not generalise from tirzepatide.

replysharereportpermalink
u/tired_ledger_ftw5 points·1 year ago

Hepatic fat or MASH or what?

replysharereportpermalink
u/elin_ferrari8 points·1 year ago

rodent dual agonist is investigation only

replysharereportpermalink
u/sena_teixeira7 points·1 year ago

glucagon co-agonism has a different safety story

replysharereportpermalink
u/teodor_szabo4 points·1 year ago

glucagon co-agonism has a different safety story

Adding to this: survodutide is doing more work than the comment implies.

replysharereportpermalink
u/marisol_frisk5 points·1 year ago

Strongly agree. The safety story is separate.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/survodutide

Survodutide-specific discussion: glucagon-receptor co-agonism, the hepatic fat and MASH resolution data, and how the side-effect profile compares with GIP-based dual agonism. Small community, high signal.

12kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/survodutide rules
  1. Glucagon co-agonism has a distinct safety story. Do not generalise from tirzepatide.
  2. MASH claims need the trial and the biopsy endpoint.
  3. Not approved. Descriptive posts only.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.